ArticleWorld journal of surgical oncology2011

CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion.

Crystal Johnson-Holiday et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.